Fátima Milhano Santos specializes in clinical proteomics, with extensive expertise in the analysis of cellular models, tissues, and biological fluids across organisms for biomarker discovery and disease progression studies. She obtained her Ph.D. in Biochemistry with distinction from UBI in 2020, with the project "Human vitreous proteome in vitreoretinal diseases" funded by FCT (SFRH/BD/112526/2015). While primarily focused on vitreoretinal diseases (vitreous proteomics) and, more recently, COVID-19 (PTI "Global Health" platform), she has also applied proteomics to study prostate cancer, paratuberculosis, and liver diseases. She has expertise in proteomics techniques such as bidimensional electrophoresis, iTRAQ/TMT, label-free quantitation, and targeted proteomics (MRM/PRM). At CNB-CSIC (Madrid), she consolidated her expertise by working with high-throughput mass spectrometers and developing automated sample preparation protocols (Opentrons and AccelerOme platform). Currently, she is a Sara Borrell postdoctoral researcher at IIS-Fundación Jiménez Díaz, applying OMICS techniques to identify extracellular vesicle-derived biomarkers and therapeutic targets, that could correlate renal and cardiovascular diseases, with emphasis on aging and senescence.